Applications for Antimetastatic Therapies

  • John D. Crissman
  • Kenneth V. Honn
Part of the Developments in Oncology book series (DION, volume 40)

Abstract

The development of therapies directed toward either interrupting the metastatic cascade or decreasing its efficiency is an intriguing concept. For the most part, clinicians and scientists have concentrated their efforts on achieving a cure of malignant neoplasms. Therapies which decrease the efficiency of the metastatic cascade have been viewed as palliative. Surgery and/or radiation therapy are the traditional and most effective methods to excise or sterilize primary and regional disease. However, cure is unlikely if successful metastatic foci have been established prior to or during initial treatment. Small metastases are not often identifiable at the time of initial diagnosis and treatment. Careful clinical staging will usually uncover large metastatic deposits in organs accessible to non-invasive maneuvers. Newer technologies (i.e., CT scans) have resulted in an increased identification of smaller metastases. Cytotoxic chemotherapy was originally reserved for palliative therapy of patients with documented disseminated cancer. Nevertheless, in selected cancers, patients with a high probability of microscopic tumor spread are commonly treated systemically with single or combination cytotoxic chemotherapy. The major exception to this is the use of hormonal therapy for neoplasms arising in the accessory sex organs. In the last decade cytotoxic chemotherapy has improved dramatically resulting in the successful treatment of many types of leukemia, lymphoma and germ cell tumors. Remarkable cytoreduction has occurred in these tumors with a significant number of patients surviving for ≥ 5 years. Unfortunately, similar success has not been evident with the more common carcinomas.

Keywords

Vascular Invasion Circulate Tumor Cell Fetal Lung Metastatic Focus Verrucous Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sugarbaker EV: Cancer metastasis: A product of tumor-host interactions. Curr. Prob. Cancer 3:3–59, 1979.CrossRefGoogle Scholar
  2. 2.
    Fisher B, Slack NH, Bross IDJ: Cancer of the breast: Size of neoplasm and prognosis. Cancer 24:1071–1080, 1969.PubMedCrossRefGoogle Scholar
  3. 3.
    Bedwani R, Vana J, Rosner D, Schmitz D, Murphy GP: Management and survival of female patients with “minimal” breast cancer: As observed in the long-term and short-term surveys of the American College of Surgeons. Cancer 47:2769–2778, 1981.PubMedCrossRefGoogle Scholar
  4. 4.
    Grinnell RS: The chance of cancer and lymphatic metastasis in small colon tumors discovered on x-ray examination. Ann. Surg. 139:132–138, 1964.CrossRefGoogle Scholar
  5. 5.
    Slack NH, Chamberlain A, Bross IDJ: Predicting survival following surgery for bronchogenic carcinoma. Chest 62:433–438, 1972.PubMedCrossRefGoogle Scholar
  6. 6.
    Lindberg R: Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 29:1446–1449, 1972.PubMedCrossRefGoogle Scholar
  7. 7.
    Keller R: Induction of macroscopic metastases via surgery. The site of primary tumor inoculum is critical. Invasion Metastasis 1:136–148, 1981.PubMedGoogle Scholar
  8. 8.
    Meyer JS, Friedman E, McCrate MM, Bauer WC: Prediction of early course of breast carcinoma by thymidine labeling. Cancer 51:1839–1886, 1983.CrossRefGoogle Scholar
  9. 9.
    Barlogie B, Ruber MN, Schumann J, Johnson TS, Drewinko B, Swartzendruber DE, Gohde W, Andreeff M, Freireich EJ: Flow cytometry in clinical cancer research. Cancer Res. 43:2982–2997, 1983.Google Scholar
  10. 10.
    van Nagel JR, Donaldson ES, Wood EG, Parker JC: The significance of vascular invasion and lymphocytic infiltration in invasive cervical carcinoma. Cancer 41:228–234, 1978.CrossRefGoogle Scholar
  11. 11.
    Crissman JD, Makuch R, Budhraja M: Histopathologic grading of squamous cell carcinoma of the uterine cervix. Cancer (In press).Google Scholar
  12. 12.
    Bask JPA, Kruver PHJ, DeSnoo-Niewlaat AJE, DeGraef S, Makkink B, Boon ME: Prognostic indicators in breast cancer - morphometric methods. Histopathology 6:327–339, 1982.CrossRefGoogle Scholar
  13. 13.
    Spratt JS, Spjut HJ: Prevalence and prognosis of individual clinical and pathologic variables associated with colorectal carcinoma. Cancer 20:1976–1985, 1967.PubMedCrossRefGoogle Scholar
  14. 14.
    Urban CH, McNeer G: The relation of the morphology of gastric carcinoma to long and short term survival. Cancer 12:1158–1162, 1959.PubMedCrossRefGoogle Scholar
  15. 15.
    Steiner PE, Maimon SN, Palmer WL, Kirsner JB: Gastric cancer: Morphologic factors in five-year survival after gastrectomy. Am. J. Pathol. 24:947–969, 1948.PubMedGoogle Scholar
  16. 16.
    Beecham JB, Halvorsen T, Kolbenstvedt A: Histologic classification, lymph node metastases, and patient survival in stage Ib cervical carcinoma. Gynecol. Oncol. 6:95–105, 1978.PubMedCrossRefGoogle Scholar
  17. 17.
    McGarvan MH, Bauer WC, Ogura JH: The incidence of cervical lymph node metastases from epidermoid carcinoma of the larynx and their relationship to certain characteristics of the primary tumor. Cancer 14:55–66, 1961.CrossRefGoogle Scholar
  18. 18.
    Crissman JD, Liu WY, Gluckman JL, Cummings G: Prognostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx. Cancer (In press).Google Scholar
  19. 19.
    Nakadate T, Suzuki M, Sato H: Quantitative study on the liberation of tumor cells into the circulating blood. Gann 70:435–446, 1979.PubMedGoogle Scholar
  20. 20.
    Weiss L, Mayhew E, Glaves Rapp D, Holmes JC: Metastatic inefficiency in mice bearing B16 melanomas. Br. J. Cancer 45:44–53, 1982.PubMedCrossRefGoogle Scholar
  21. 21.
    Nealon TF, Nkongho A, Grossi C, Gillooley J: Pathologic identification of poor prognosis stage I (T1N0M0) cancer of the breast. Ann. Surg. 190:129–132, 1979.PubMedCrossRefGoogle Scholar
  22. 22.
    Weigand RA, Isenberg WM, Russo J, Brennan MJ, Rich MA: Blood vessel invasion and axillary node involvement as prognostic indicators for human breast cancer. Cancer 50:962–969, 1982.PubMedCrossRefGoogle Scholar
  23. 23.
    Kodama Y, Inokuchi K, Soejima K, Matsusaka T, Okamura T: Growth patterns and prognosis in early gastric carcinoma. Cancer 51:320–326, 1983.PubMedCrossRefGoogle Scholar
  24. 24.
    Baltzer J, Lohe J, Kopcke W, Zauder J: Histologic criteria for the prognosis in patients with operated squamous cell carcinoma of the cervix. Gynecol. Oncol. 13:184–194, 1982.PubMedCrossRefGoogle Scholar
  25. 25.
    Stendahl V, Eklund G, Willen R: Prognosis of invasive squamous cell carcinoma of the uterine cervix: A comparative study of the predictive values of clinical staging Ib-III and a histopathologic malignancy grading system. Int. J. Gynecol. Pathol. 2:42–54, 1983.PubMedCrossRefGoogle Scholar
  26. 26.
    Bell JT, Burney SW, Friedell GH: Blood vessel invasion in human bladder cancer. J. Urol. 105:675–678, 1971.PubMedGoogle Scholar
  27. 27.
    Copeland EM, Miller LD, Jones RS: Prognostic factors in carcinoma of the colon and rectum. Am. J. Surg. 116:875–881, 1968.PubMedCrossRefGoogle Scholar
  28. 28.
    Talbot IC, Ritchie S, Leighton M, Hughes AO, Bussey HJR, Morson BC: Invasion of veins by carcinoma of the rectum: Method of detection, histologic features and significance. Histopathology 5:141–163, 1981.PubMedCrossRefGoogle Scholar
  29. 29.
    Khankhanian N, Mauligit GM, Russell WO, Schimek M: Prognostic significance of vascular invasion in colorectal cancer of Dukes’ B class. Cancer 39:1195–1200, 1977.PubMedCrossRefGoogle Scholar
  30. 30.
    deMascarel A, Coindre JM, deMascarel I, Trojani M, Maree D, Hoerni B: The prognostic significance of specific histologic features of carcinoma of the colon and rectum. Surg. Gynecol. Obstet. 153:511–514, 1981.Google Scholar
  31. 31.
    Tannock IF: The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumor. Br. J. Cancer 22:258–273, 1968.PubMedCrossRefGoogle Scholar
  32. 32.
    Butler TP, Gullino PM: Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res. 35:512–516, 1975.PubMedGoogle Scholar
  33. 33.
    Roberts S, Jonasson 0, Long L, McGrew EA, McGrath R, Cole WH: Relationship of cancer cells in the circulating blood to operation. Cancer 15:232–240, 1962.PubMedCrossRefGoogle Scholar
  34. 34.
    Liotta LA, Kleinerman J, Saidel GM: Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res. 34:997–1004, 1974.PubMedGoogle Scholar
  35. 35.
    Engell HC: Cancer cells in the circulating blood. Acta Chir. Scand. (Suppl.) 210:10–70, 1955.Google Scholar
  36. 36.
    Engell HC: Cancer cells in the blood. A five to nine year follow-up study. Ann. Surg. 149:457–461, 1959.PubMedCrossRefGoogle Scholar
  37. 37.
    Liotta LA, Kleinerman J, Saidel GM: The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res. 36:889–894, 1976.PubMedGoogle Scholar
  38. 38.
    March MC: Tumor massage and metastases in mice. Cancer Res. 11:101–107, 1927.Google Scholar
  39. 39.
    Riggins RS, Ketcham AS: Effect of incision biopsy on the development of experimental tumor metastases. J. Surg. Res. 5:200–206, 1965.PubMedCrossRefGoogle Scholar
  40. 40.
    Keller R: Induction of macroscopic metastases via surgery. Invasion Metastasis 1:136–148, 1981.PubMedGoogle Scholar
  41. 41.
    Turnbull RB, Kyle K, Watson FR, Spratt J: Cancer of the colon: The influence of the no-touch isolation technic on survival rates. Ann. Surg. 166:420–427, 1967.PubMedCrossRefGoogle Scholar
  42. 42.
    Hart IR, Fidler IJ: Cancer invasion and metastasis. Quart Rev. Biol. 55:121–142, 1980.PubMedCrossRefGoogle Scholar
  43. 43.
    Wheelock EF, Robinson MK: Biology of disease. Endogenous control of the neoplastic process. Lab. Invest. 48:120–139, 1983.PubMedGoogle Scholar
  44. 44.
    Fidler IJ: Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res. 38:2651–2660, 1978.PubMedGoogle Scholar
  45. 45.
    Poste G, Doll J, Brown AE, Tzeng J, Zeidman I: Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastasis. Cancer Res. 42:2770–2778, 1982.PubMedGoogle Scholar
  46. 46.
    Viadama E, Bross IDJ, Pickren JW: An autopsy study of some routes of dissemination of cancer of the breast. Br. J. Cancer 27:336–340, 1973.CrossRefGoogle Scholar
  47. 47.
    Viadama E, Bross IDJ, Pickren JW: The metastatic spread of cancers of the digestive system in man. Oncology 35:114–126, 1978.CrossRefGoogle Scholar
  48. 48.
    Ketcham AS, Ryan JJ, Wexler H: The shedding of viable circulating tumor cells by pulmonary metastases in mice. Ann. Surg. 169:297–299, 1969.PubMedCrossRefGoogle Scholar
  49. 49.
    Ketcham AS, Wexler H, Chretien PB: The metastatic potential of experimental pulmonary metastases. J. Surg. Red. 15:45–52, 1973.CrossRefGoogle Scholar
  50. 50.
    Hoover HC, Ketcham AS: Metastasis of metastases. Am. J. Surg. 130:405–411, 1975.PubMedCrossRefGoogle Scholar
  51. 51.
    Kinsey DL: An experimental study of preferential metastasis. Cancer 13:674–676, 1960.PubMedCrossRefGoogle Scholar
  52. 52.
    Sugarbaker EV, Cohen AM, Ketcham AS: Do metastases metastasize? Ann. Surg. 174:161–166, 1971.PubMedCrossRefGoogle Scholar
  53. 53.
    Hart IR, Fidler IJ: Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res. 40:2281–2287, 1980.PubMedGoogle Scholar
  54. 54.
    Sloane BF, Dunn JR, Honn KV: Lysosomal cathepsin B: Correlation with metastatic potential. Science 212:1151–1153, 1981.PubMedCrossRefGoogle Scholar
  55. 55.
    Fidler IJ: Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res. 35:218–224, 1975.PubMedGoogle Scholar
  56. 56.
    Mantovani A, Giavazzi R, Alessandri G, Spreafico F, Garrattini S: Characterization of tumor lines derived from spontaneous metastases of a transplanted murine sarcoma. Eur. J. Cancer 17:71–76, 1981.PubMedCrossRefGoogle Scholar
  57. 57.
    Poste G, Doll J, Brown AE, Tzeng J, Zeidman I: Comparison of the metastatic properties of 816 melanoma clones isolated from cultured cell lines, subcutaneous tumors and individual lung metastases. Cancer Res. 42:2770–2778, 1982.PubMedGoogle Scholar
  58. 58.
    Honn KV, Meyer J, Neagos G, Henderson T, Westley C, Ratanatharathorn V: Control of tumor growth and metastasis with prostacyclin and thromboxane synthetase inhibitors: Evidence for a new antitumor and antimetastatic agent (Bay g 6575). IN: Jamieson GA, (ed.) Interaction of Platelets and Tumor Cells. Alan R. Liss, New York, pp. 295–328, 1982.Google Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1986

Authors and Affiliations

  • John D. Crissman
  • Kenneth V. Honn

There are no affiliations available

Personalised recommendations